TAE Life Sciences

[Available On-Demand]
Search General Info
Search Education
Search Partnering Companies
TAE Life Sciences (TLS) is a biotechnology company developing a combination cancer therapy based on Boron Neutron Capture Therapy (BNCT) to improve the lives of patients with aggressive, inoperable, and recurrent cancers. TLS is the only company developing small molecule and antibody therapeutics along with in-hospital neutron source to enable next-generation BNCT as a first-line treatment for patients globally.
Company Type:
Company Website:
Company HQ State:
California
Company HQ Country:
United States
Year Founded:
2017
Main Therapeutic Focus:
Lead Product in Development:
Boronophenylalanine (BPA), Antibody Boron Conjugates (ABC™), and nanoparticles
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
CEO
TAE Life Sciences